Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C24H25NO4.C4H11NO3 |
| Molecular Weight | 512.5946 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
NC(CO)(CO)CO.OC(=O)C1=CC2=C(C=C1)C(=O)N([C@H](CCC3CCCCC3)C4=CC=CC=C4)C2=O
InChI
InChIKey=UEMZZDQCKZSDJA-ZMBIFBSDSA-N
InChI=1S/C24H25NO4.C4H11NO3/c26-22-19-13-12-18(24(28)29)15-20(19)23(27)25(22)21(17-9-5-2-6-10-17)14-11-16-7-3-1-4-8-16;5-4(1-6,2-7)3-8/h2,5-6,9-10,12-13,15-16,21H,1,3-4,7-8,11,14H2,(H,28,29);6-8H,1-3,5H2/t21-;/m1./s1
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| JTP-27536 [(+)-1,3-dihydroxy-2-hydroxymethylpropyl-2-ammonium 2-[(R)-3-cyclo-hexyl-1-phenylpropyl]-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxylate monohydrate], a novel inhibitor of immunoglobulins and interleukin-5 with anti-inflammatory properties in mouse allergic dermatitis model. | 2005-07 |
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
216681-21-9
Created by
admin on Mon Mar 31 22:16:06 GMT 2025 , Edited by admin on Mon Mar 31 22:16:06 GMT 2025
|
PRIMARY | |||
|
34RCU15W5B
Created by
admin on Mon Mar 31 22:16:06 GMT 2025 , Edited by admin on Mon Mar 31 22:16:06 GMT 2025
|
PRIMARY | |||
|
11489138
Created by
admin on Mon Mar 31 22:16:06 GMT 2025 , Edited by admin on Mon Mar 31 22:16:06 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD